1. Home
  2. SNOA vs LGHL Comparison

SNOA vs LGHL Comparison

Compare SNOA & LGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNOA
  • LGHL
  • Stock Information
  • Founded
  • SNOA 1999
  • LGHL 2015
  • Country
  • SNOA United States
  • LGHL Singapore
  • Employees
  • SNOA N/A
  • LGHL N/A
  • Industry
  • SNOA Biotechnology: Pharmaceutical Preparations
  • LGHL Investment Bankers/Brokers/Service
  • Sector
  • SNOA Health Care
  • LGHL Finance
  • Exchange
  • SNOA Nasdaq
  • LGHL Nasdaq
  • Market Cap
  • SNOA 3.7M
  • LGHL 4.3M
  • IPO Year
  • SNOA 2007
  • LGHL N/A
  • Fundamental
  • Price
  • SNOA $2.65
  • LGHL $0.16
  • Analyst Decision
  • SNOA
  • LGHL
  • Analyst Count
  • SNOA 0
  • LGHL 0
  • Target Price
  • SNOA N/A
  • LGHL N/A
  • AVG Volume (30 Days)
  • SNOA 44.7K
  • LGHL 5.4M
  • Earning Date
  • SNOA 02-06-2025
  • LGHL 01-28-2025
  • Dividend Yield
  • SNOA N/A
  • LGHL N/A
  • EPS Growth
  • SNOA N/A
  • LGHL N/A
  • EPS
  • SNOA N/A
  • LGHL N/A
  • Revenue
  • SNOA $13,547,000.00
  • LGHL $13,659,110.00
  • Revenue This Year
  • SNOA $23.89
  • LGHL N/A
  • Revenue Next Year
  • SNOA $25.45
  • LGHL N/A
  • P/E Ratio
  • SNOA N/A
  • LGHL N/A
  • Revenue Growth
  • SNOA 11.81
  • LGHL 11.35
  • 52 Week Low
  • SNOA $2.44
  • LGHL $0.13
  • 52 Week High
  • SNOA $9.40
  • LGHL $1.55
  • Technical
  • Relative Strength Index (RSI)
  • SNOA 47.13
  • LGHL 44.11
  • Support Level
  • SNOA $2.52
  • LGHL $0.14
  • Resistance Level
  • SNOA $2.80
  • LGHL $0.17
  • Average True Range (ATR)
  • SNOA 0.13
  • LGHL 0.03
  • MACD
  • SNOA 0.00
  • LGHL -0.00
  • Stochastic Oscillator
  • SNOA 39.39
  • LGHL 10.64

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

About LGHL Lion Group Holding Ltd.

Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.

Share on Social Networks: